Samantha Sartori

Assistant Professor / Biostatistician / Epidemiologist

Icahn School of Medicine at Mount Sinai

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Samantha Sartori is an Assistant Professor, Biostatistician, and Epidemiologist at the Icahn School of Medicine at Mount Sinai in the United States. Her research primarily focuses on clinical outcomes related to percutaneous coronary intervention, with particular attention to factors such as inflammatory risk and bleeding complications. Recent articles authored by Dr. Sartori explore the associations of neutrophil-to-lymphocyte ratio, cholesterol levels, and diabetes status in diverse patient populations undergoing interventional procedures.

Articles (29)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (7)

Mauro Chiarito

Humanitas University

ITALY

View details

Pamela Douglas

Duke University

UNITED STATES

View details

Adnan Kastrati

Ludwig-Maximilians-Universität München

GERMANY

View details

Bimmer Claessen

Amsterdam University Medical Centers

NETHERLANDS

View details

Ridhima Goel

Chief Resident

SUNY Downstate Medical Center

UNITED STATES

View details

Zhongjie Zhang

Mount Sinai Hospital

UNITED STATES

View details

Vijay Kunadian

Newcastle University

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Samantha Sartori

Research Interests

Explore related searches

Contact this professor

About

Articles (29)

Association of Neutrophil-to-Lymphocyte Ratio With Clinical Outcomes After Percutaneous Coronary Intervention

Residual cholesterol and inflammatory risk in statin-treated patients undergoing percutaneous coronary intervention

Percutaneous Coronary Intervention Outcomes by 5 Major Race and Ethnic Subgroups

1-Month or 3-Month DAPT in Women and Men at High Bleeding Risk Undergoing PCI

Prognostic impact of residual inflammatory and triglyceride risk in statin-treated patients with well-controlled LDL cholesterol and atherosclerotic cardiovascular disease

Clinical Outcomes According to the Extent of Atherosclerotic Disease in Female Patients Undergoing Transcatheter Aortic Valve Replacement: An Analysis From the WIN‐TAVI Registry

Impact of ticagrelor with or without aspirin on total and recurrent bleeding and ischaemic events after percutaneous coronary intervention: a sub-study of the TWILIGHT trial

Predictive Ability of the Academic Research Consortium High Bleeding Risk Criteria in Patients Undergoing Percutaneous Coronary Intervention According to Body Mass Index

Geographic Mapping of Gender Disparities in Authorship of Cardiovascular Literature

Significance of diabetes mellitus status in patients undergoing percutaneous left main coronary artery intervention

Mortality After Procedural or Spontaneous Myocardial Infarction

Outcomes Following Percutaneous Coronary Intervention in Patients With Multivessel Disease Who Were Recommended for But Declined Coronary Artery Bypass Graft Surgery

Prevalence and prognostic impact of complex percutaneous coronary intervention among octogenarians

Incidence and Impact of Contrast-Associated Acute Kidney Injury in Patients With High-Bleeding Risk Undergoing Percutaneous Coronary Intervention

Impact of Bleeding Risk and Inflammation on Cardiovascular Outcomes After Percutaneous Coronary Intervention

Prognostic impact of in‐stent restenosis in normal weight, overweight, and obese patients undergoing percutaneous coronary intervention

Prognostic impact of peripheral artery disease in patients with and without high bleeding risk undergoing percutaneous coronary intervention

Predictive value of the thrombotic risk criteria proposed in the 2023 ESC guidelines for the management of ACS: insights from a large PCI registry

Validation of a high bleeding risk definition in cancer patients undergoing percutaneous coronary intervention

Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO‐3 randomized trial

Thrombotic risk in patients with acute coronary syndromes discharged on prasugrel or clopidogrel: results from the PROMETHEUS study

Ticagrelor with or without aspirin in high-risk patients with anaemia undergoing percutaneous coronary intervention: a subgroup analysis of the TWILIGHT trial

Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney disease

Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials

Perioperative management of P2Y12 inhibitors in patients undergoing cardiac surgery within 1 year of PCI

Ticagrelor monotherapy after PCI in patients with concomitant diabetes mellitus and chronic kidney disease: TWILIGHT DM-CKD

Two‐year clinical outcomes after successful transcatheter aortic valve implantation with balloon‐expandable versus self‐expanding valves: A subanalysis of the GALILEO trial

Antiplatelet therapy in patients with atrial fibrillation: a systematic review and meta-analysis of randomized trials

Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysis

Collaborators (7)

Mauro Chiarito

Pamela Douglas

Adnan Kastrati

Bimmer Claessen

Ridhima Goel

Zhongjie Zhang

Vijay Kunadian

Make your next move.